Healthcare -
Biotechnology - NASDAQ - US
$ 29.74
-2.14 %
$ 3.7 B
Market Cap
-14.65
P/E
APLS - OTHER FINANCING ACTIVITIES
Other Financing Activities APLS - Apellis Pharmaceuticals, Inc.
10.1 M
LAST VALUE
-7.71%
2 YEAR CAGR
70.14%
5 YEAR CAGR
3.12%
10 YEAR CAGR